Get to know our innovation community as we find solutions together.


The BioCentury Show:

Scaling Singapore Biotech

Speaking on The BioCentury Show, CEO Khoo Shih discussed ClavystBio’s global strategy for capitalizing on the ascendant energy and attention being devoted to Singapore biotech.

Posted on 16 Feb 2024


ClavystBio Conversations:

Fostering Venture Creation

Drug discovery and development are long term endeavors that require partnership and commitment across the ecosystem. 65LAB partners Thomas Hanke (Evotec), Christina Isacson (Lightstone Ventures), and Koh Shuwen (NUS) discuss what it takes to foster venture creation and build global biotech companies.

65LAB is a unique company creation vehicle established by ClavystBio, Evotec, Leaps by Bayer, Lightstone Ventures, Polaris Partners, and the Polaris Innovation Fund to leverage breakthrough science from A*STAR, DUKE-NUS and NUS for human health impact.

Posted on 27 Nov 2023


ClavystBio Conversations:

The Growing Pains of Getting a Product Into Clinic

Hummingbird Bioscience CEO Piers Ingram and MediSix Therapeutics CEO Andrew Bruce discuss their experiences and the different paths their companies have taken to bring their leads assets into the clinic and ultimately patients globally.

Posted on 11 Sep 2023


ClavystBio Conversations:

Building a Biotech Company Across Two Continents

Allay Therapeutics CEO Adam Gridley and Engine Biosciences CEO Jeffrey Lu discuss the value in creating a global company, working across the US and Singapore.

Posted on 10 Jan 2023


ClavystBio Conversations:

The Chemistry of Academia and Industry

CoVBio CSO Prof Wang Linfa and CEO Dr Rosemary Tan discuss their partnership and what makes it successful.

Posted on 01 Dec 2022